CheckMan Stock Market Overview

Kroger said Wednesday it plans to buy regional grocer and pharmacy retailer Giant Eagle in a deal valued at $1.65 billion.

The first half of 2026 capped a historic stretch for the ETF industry. Despite global returns struggling and macro uncertainties sending equities down 0.9% in June, assets poured into U.S.-listed ETFs at an unprecedented rate.

Investor interest in dividend ETFs is increasing according to recent analysis. A monthly update from State Street Investment Management's Global Head of Research Strategists Matt Bartolini assessed a few notable trends including dividend ETF flows on the rise.

Larry Kudlow spent the run-up to the July 4th holiday broadcasting from Washington, D.C.

Meta's stock is soaring on signs it could be on the verge of launching a new business.

Tesla on Thursday launched a six-seater long wheelbase version of ​its best-selling Model Y SUV in the U.S., aiming to ‌boost sales of its electric vehicles after the removal of a key tax credit.

McKesson's growth in specialty pharma, oncology services and tech-driven solutions is boosting earnings, but policy and execution risks remain in focus.

Alcon's new platforms, lenses and dry eye momentum support growth, but macro pressures, tariffs and fierce competition weigh on its outlook.

LQDA's Yutrepia launch is gaining traction, with $130 million in Q1 sales, rising prescriptions and profitability as the company expands in PAH.

VCYT's 117% stock surge is driven by durable growth plans, Afirma demand, TrueMRD progress, international IVD efforts and a debt-free balance sheet.